Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Dendritic cells treated with IL-15 and a p38 MAP kinase inhibitor antagonize regulatory T cell activation and expansion and drive CD4+ Th17 responses to ovarian tumor antigens. In preparation

Cannon M, Rose DL, Kozak KL, O'Brien TJ, Cobos E, Chiriva-Internati M. Dendritic cells treated with IL-15 and a p38 MAP kinase inhibitor antagonize regulatory T cell activation and expansion and drive CD4+ Th17 responses to ovarian tumor antigens. In preparation. 2009.


collapse authors with profiles